Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus.

Stephen JollesMauricette MichalletCarlo AgostiniMichael H AlbertDavid EdgarRoberto RiaLivio TrentinVincent Lévy

Published in: European journal of haematology (2021)

Recommendations have been developed with the aim of providing guidance for the use of IgRT to prevent severe, recurrent or persistent infections in patients with HM and SAD.

Keyphrases

early onset
clinical practice
replacement therapy
drug induced